A Virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in Non-Human Primates
A. Fowler, K. K. A. Van Rompay, M. Sampson, J. Leo, J. K. Watanabe, J. L. Usachenko, R. Immareddy, D. M. Lovato, J. T. Schiller, A. T. Remaley, B. Chackerian
A bivalent PCSK9 vaccine using virus-like particles reduces LDL-cholesterol in non-human primates without statins, showing vaccine efficacy in cholesterol management.
bioRxiv · May 15, 2023Immunology